Whether you are looking for FAQ’s or product documents we hope you find what you need here but feel free to reach out if you dont.
Sentinel Lymph Node Biopsy (SLNB) has been widely accepted as the replacement for axillary lymph node dissection as the staging procedure for early node-negative breast cancer.
Traditionally SLNB involves injecting radioactive drugs which are dependent on nuclear medicine availability and blue dyes that can put a patient at risk for anaphylaxis and skin necrosis.
Magnetic SLNB uses a single tracer that offers the freedom to be injected in the operating room or up to seven days beforehand to improve scheduling and the patient experience.
At Mammotome, we understand the importance of driving efficiencies. Our comprehensive stereo solutions and wire-free lesion localization technology can help you maximize productivity and drive better patient-focused care from biopsy through surgery.
HydroMARK’s exclusive hydrogel technology provides up to 12 months of Ultrasound visibility, and is visible even after Neoadjuvant Chemotherapy.
Mammotome revolve ST automatically collects and organizes tissue samples into individual collection chambers.
Specimen radiography system which can immediately and directly analyze biopsy cores at the site of the biopsy.
We offer a wide variety of breast biopsy markers for stereotactic procedures that are compatible with both Mammotome breast biopsy devices as well as other breast biopsy devices available on the market today.
© 2021 Devicor Medical Products, Inc., part of Leica Biosystems.
